Velarde, Francesca
Ezquerra, Sarah
Delbruyere, Xavier
Caicedo, Andres
Hidalgo, Yessia http://orcid.org/0000-0002-5203-3686
Khoury, Maroun
Funding for this research was provided by:
ANID FONDECYT Regular (1211749)
ANID Basal Funding for Scientific and Technological Center of Excellence, IMPACT (FB210024)
ANID FONDECYT de IniciaciĆ³n (11221017)
Article History
Received: 9 October 2021
Revised: 27 January 2022
Accepted: 11 February 2022
First Online: 5 March 2022
Declarations
:
: MK is the chief scientific officer of Cells for Cells and Regenero, the Chilean consortium for regenerative medicine. YH received a stipend from Regenero. AC is the chief executive officer of Dragon BioMed with spin-off of the Universidad San Francisco de Quito in regenerative medicine. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: Not applicable.
: Not applicable.
: Not applicable.